-
September 27: The Week in Cancer News
A study examines how poor and minority patients are more likely to be diagnosed with cancer in the emergency room, and a cancer survivor considers the lasting effects of chemotherapy.
by Bradley Jones
-
Patients and Caregivers Raise Their Voices
The fall 2019 Cancer Today tells the stories of advocates who are using the internet to amplify their voices, patients who are navigating the world of complementary medicine and researchers who are devising new immunotherapies.
by Kevin McLaughlin
-
September 20: Week in Cancer News
Article describes efforts to support cancer survivors, radiation meeting focuses on treatment de-escalation, and studies show that brain tumor cells have their own neural network.
by Marci A. Landsmann
-
What to Do About Lymphedema?
In a randomized study, weight loss and home-based exercise did not improve lymphedema symptoms in breast cancer survivors.
by Anna Azvolinsky
-
September 13: The Week in Cancer News
Some cancer drugs being tested in clinical trials do not work the way researchers thought they did, and ringing a bell following radiation therapy may increase distress for patients.
by Kate Yandell
-
HIV Can Worsen Cancer Treatment Outcomes
People with HIV who develop certain cancers are more likely to die from them than patients without HIV—even if they receive similar treatment.
by Jon Kelvey
-
September 6: The Week in Cancer News
Organizations release guidelines on reducing breast cancer risk using medications, and a palliative care doctor discusses the pros and cons of dying at home.
by Kate Yandell
-
Finding Support in Unlikely Places
After her diagnosis with ovarian cancer, Patricia Anne Ward noticed that some friends and family pulled away. She found connection outside her usual circles.
by Patricia Anne Ward
-
August 30: The Week in Cancer News
A study looks at hormone therapy and breast cancer risk, and researchers take a closer look at marijuana use in young cancer patients.
by Marci A. Landsmann
-
A Researcher Attends a Conference, This Time as a Patient Advocate
My most meaningful moments at my first cancer research conference came from embracing my experience as a patient—not as a researcher.
by Jamie Aten
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona